Amgen Inc. | Patient Daily

Amgen Inc.

Press release submission | Dec 20, 2021

FDA Approves Otezla® (Apremilast) for the Treatment of Adult Patients With Plaque Psoriasis, Regardless of Severity Level

Press release submission | Sep 5, 2021

New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps

Press release submission | Mar 15, 2019

AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke

Carol Ostrow | Dec 15, 2017

Amgen Foundation commits $500,000 to help southern California wildfire victims

Carol Ostrow | Dec 10, 2017

Amgen's Repatha wins FDA approval

Carol Ostrow | Dec 8, 2017

Amgen presents at Evercore conference

Mark Iandolo | Nov 1, 2017

Cancer information awareness campaign features conversations with Joan Lunden

Kathy Adams | Oct 22, 2017

Amgen, Boston Children's Hospital team up for study on unusual pain response

Trending

Patient Daily | Mar 27, 2025

Healthcare professionals recognized at National Breathe Free conference for outstanding dedication

Patient Daily News Service | Mar 28, 2025

Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.

+ Pharmaceuticals

Patient Daily | Mar 31, 2025

Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'

+ Pharmaceuticals

Patient Daily | Apr 1, 2025

American Lung Association responds to HHS budget cuts